Telix share price set to climb on revenue guidance
MELBOURNE: Cancer diagnostics specialist Telix Pharmaceuticals has upgraded its full-year revenue forecast following ...
To read the full story...SUBSCRIBE NOWExisting Subscribers Login Below:
Log In
